New study illuminates why cancers caused by BRCA mutations recur

byPerelman School of Medicine at the University of PennsylvaniaThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained gr

Updated on: January 12,2024

New study illuminates why cancers caused by BRCA mutations recur

byPerelman School of Medicine at the University of PennsylvaniaThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained gr

Updated on:January 12,2024

Cooling glioblastoma to room temperature extends survival in preclinical study

by Jenny Owen,Emory UniversityConceptual model of a translational device to deliver cytostatic hypothermia for GBM. Representative diagram of a patient with GBM implanted with an envisioned cyto

Updated on: January 30,2024

Cooling glioblastoma to room temperature extends survival in preclinical study

by Jenny Owen,Emory UniversityConceptual model of a translational device to deliver cytostatic hypothermia for GBM. Representative diagram of a patient with GBM implanted with an envisioned cyto

Updated on:January 30,2024

Novel theranostic approach for treating pancreatic cancer patients shows promise

by Society of Nuclear Medicine and Molecular Imaging(A)18FDG PET before177Lu-3BP-227 therapy. Red oval: primary tumor; arrows: liver metastases. (B, upper panel) Axial CT section; primary

Updated on: April 09,2024

Novel theranostic approach for treating pancreatic cancer patients shows promise

by Society of Nuclear Medicine and Molecular Imaging(A)18FDG PET before177Lu-3BP-227 therapy. Red oval: primary tumor; arrows: liver metastases. (B, upper panel) Axial CT section; primary

Updated on:April 09,2024

New tool to predict people's risk of developing lung cancer within the next ten years

by Jane Icke,University of NottinghamCredit: Pixabay/CC0 Public DomainResearchers at the University of Nottingham have helped to develop a new tool called "CanPredict," which is able t

Updated on: February 03,2024

New tool to predict people's risk of developing lung cancer within the next ten years

by Jane Icke,University of NottinghamCredit: Pixabay/CC0 Public DomainResearchers at the University of Nottingham have helped to develop a new tool called "CanPredict," which is able t

Updated on:February 03,2024

Ethnic diversity and disparities in access to genetic testing impact prostate cancer development and treatment

byEuropean Society for Medical OncologyCredit: Unsplash/CC0 Public DomainMore than 1.4 million men were diagnosed with prostate cancer in 2020 globally, but the molecular characteristics of the

Updated on: January 22,2024

Ethnic diversity and disparities in access to genetic testing impact prostate cancer development and treatment

byEuropean Society for Medical OncologyCredit: Unsplash/CC0 Public DomainMore than 1.4 million men were diagnosed with prostate cancer in 2020 globally, but the molecular characteristics of the

Updated on:January 22,2024

Software improves the ability to pinpoint specific genetic mutations that drive cancer

by Colin Poitras,Yale UniversityCredit: Unsplash/CC0 Public DomainA new open-source software package calledcancereffectsizeRdeveloped by the Townsend Lab greatly improves the ability

Updated on: January 03,2024

Software improves the ability to pinpoint specific genetic mutations that drive cancer

by Colin Poitras,Yale UniversityCredit: Unsplash/CC0 Public DomainA new open-source software package calledcancereffectsizeRdeveloped by the Townsend Lab greatly improves the ability

Updated on:January 03,2024

Direct-acting antivirals still underused in hep C-related liver cancer

by Lori SolomonDirect-acting antiviral agents (DAAs) remain underutilized in patients with hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC), according to a study presented at The Liver M

Updated on: April 10,2024

Direct-acting antivirals still underused in hep C-related liver cancer

by Lori SolomonDirect-acting antiviral agents (DAAs) remain underutilized in patients with hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC), according to a study presented at The Liver M

Updated on:April 10,2024

Advancing neuropathology with AI-driven classification of diffuse gliomas

by Liu Jia,Chinese Academy of SciencesTen examples of classification results on the external testing sets. Credit:Nature Communications(2023). DOI: 10.1038/s41467-023-41195-9Diffuse

Updated on: March 30,2024

Advancing neuropathology with AI-driven classification of diffuse gliomas

by Liu Jia,Chinese Academy of SciencesTen examples of classification results on the external testing sets. Credit:Nature Communications(2023). DOI: 10.1038/s41467-023-41195-9Diffuse

Updated on:March 30,2024

Study finds adding ribociclib to hormone therapy reduces the risk of breast cancer recurrence

byUniversity of California, Los AngelesCredit: Miguel Á. Padriñán from PexelsA new treatment approach that combines a targeted therapy drug with hormone therapy significantly increased the amoun

Updated on: March 30,2024

Study finds adding ribociclib to hormone therapy reduces the risk of breast cancer recurrence

byUniversity of California, Los AngelesCredit: Miguel Á. Padriñán from PexelsA new treatment approach that combines a targeted therapy drug with hormone therapy significantly increased the amoun

Updated on:March 30,2024

Low-dose radiotherapy boost helps prevent local recurrence with better cosmetic outcomes in young breast cancer patients

by European Organisation for Research and Treatment of CancerThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Ima

Updated on: March 30,2024

Low-dose radiotherapy boost helps prevent local recurrence with better cosmetic outcomes in young breast cancer patients

by European Organisation for Research and Treatment of CancerThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Ima

Updated on:March 30,2024

Adding pembrolizumab to chemo improves survival in cervical cancer, finds study

by Elana GotkineFor women with persistent, recurrent, or metastatic cervical cancer, adding pembrolizumab to chemotherapy, with or without bevacizumab, is associated with improved overall and progress

Updated on: January 23,2024

Adding pembrolizumab to chemo improves survival in cervical cancer, finds study

by Elana GotkineFor women with persistent, recurrent, or metastatic cervical cancer, adding pembrolizumab to chemotherapy, with or without bevacizumab, is associated with improved overall and progress

Updated on:January 23,2024

Blocking glycogen, a key energy source, could slow or prevent ovarian cancer spread

by University of Chicago Medical CenterPathways of early (proliferation) and late (proliferation, invasion and widespread) metastasis. Credit: Study authors working withCell MetabolismIn ne

Updated on: April 01,2024

Blocking glycogen, a key energy source, could slow or prevent ovarian cancer spread

by University of Chicago Medical CenterPathways of early (proliferation) and late (proliferation, invasion and widespread) metastasis. Credit: Study authors working withCell MetabolismIn ne

Updated on:April 01,2024